The dominant story across April 28 was a sharp turn higher in energy prices and the ripple effects that followed through equities, rates-sensitive sectors, and commodities. U.S. oil first moved above $100 a barrel as the Iran stalemate kept the Strait of Hormuz shut, then later topped $110, a move that helped push S&P 500 futures lower and sent gold and silver down. The oil move also framed a series of company-specific headlines: JetBlue said higher fuel costs widened its quarterly loss, prompting it to cut capacity and raise fares, while Shell’s $22 billion ARC Resources deal was presented as increasing the odds of LNG Canada expansion moving ahead. The day’s commodity backdrop was reinforced by a separate note that oil above $110 coincided with a plunge in gold and silver, underscoring how quickly the market shifted toward an energy-shock narrative rather than a broad risk-on tone. Earnings and guidance updates provided the other major thread, with several companies using quarterly results to lift full-year outlooks. Pentair beat Q1 estimates and raised FY2026 EPS guidance to $5.30-$5.40, while Commvault reported a Q4 earnings beat and raised FY27 outlook, with shares up 12% on the day’s note. Centene lifted its 2026 adjusted EPS outlook to greater than $3.40 and said Marketplace pretax margin was around 3%, and American Tower raised its 2026 outlook by $0.12 per share. Mobileye also posted a Q1 beat and raised fiscal 2026 guidance, while Franklin Electric increased its 2026 outlook to $2.17 billion-$2.24 billion in sales and $4.40-$4.60 in adjusted EPS. Elsewhere, LendingClub kept its $1.65-$1.80 EPS outlook intact while projecting $3.0 billion-$3.1 billion in Q2 2026 originations, a 31% growth rate, and UnitedHealth reported a Q1 2026 beat on both revenue and earnings estimates. These updates pointed to a market still rewarding companies that could either beat or preserve guidance despite a more uncertain macro backdrop. Deal activity and strategic announcements also stood out. Eli Lilly announced a gene therapy deal with Profluent worth up to $2.25 billion, adding another large biotech partnership to the day’s tape. In energy, Oracle expanded its Bloom Energy fuel-cell deal to up to 2.8 gigawatts, linking the software giant to a much larger clean-power capacity buildout. Shell’s $22 billion ARC Resources transaction was framed as a possible step toward LNG Canada expansion, while Agnico Eagle agreed to buy Rupert Resources’ undeveloped gold deposit at a 67% premium, highlighting continued appetite for resource assets even as gold itself fell with the oil spike. On the capital markets side, Churchill Capital XII upsized its IPO to $360 million at $10 per unit, and ASX rare earths name OCN jumped 68% on acquisition news. These headlines showed that dealmaking remained active across energy, biotech, mining, and special situations. There was also a clear cluster of policy, legal, and regional labor headlines that added to the day’s crosscurrents. Bayer’s Roundup litigation fight reached the U.S. Supreme Court, and shares slid after a split ruling, keeping the long-running legal overhang in focus. Spain’s unemployment rate rebounded above 10% in Q1, signaling labor-market deterioration in a major euro-area economy. In the industrial and infrastructure space, Eccles battery storage system financing of $245 million advanced the project, while the National Mining Museum strike ended after workers secured a 10.5% pay rise. Dividend and capital-return headlines also appeared throughout the day, including Energy Transfer’s quarterly dividend of $0.3375 per share with a 7.09% forward yield, Triton’s four quarterly preferred dividends, and InsCorp’s $0.12 quarterly dividend. By the close, the main things to watch into the next session were whether oil can hold above the $110 level, whether the higher fuel-cost pressure spreads further through airlines and other transport names, and whether the day’s wave of upbeat earnings guidance can offset the drag from commodities, legal risk, and macro softness.
Key themes
Oil Shock Drives The Tape
U.S. oil first moved above $100 a barrel as the Iran stalemate kept Hormuz shut, then later topped $110 per barrel. The move pressured S&P 500 futures and helped push gold and silver lower, while also feeding directly into company headlines such as JetBlue’s wider quarterly loss and fare increases.
Guidance Raises Across Sectors
Several companies used quarterly updates to lift outlooks, including Pentair, Commvault, Centene, American Tower, Mobileye, Franklin Electric, and Incyte. LendingClub also kept its EPS outlook intact while projecting 31% origination growth, and UnitedHealth reported a Q1 beat on revenue and earnings.
Energy And Resource Deals
Shell’s $22 billion ARC Resources deal was framed as a step that could improve the odds of LNG Canada expansion, while Oracle expanded its Bloom Energy fuel-cell deal to up to 2.8 gigawatts. Agnico Eagle’s purchase of Rupert Resources’ undeveloped gold deposit at a 67% premium and OCN’s 68% jump on acquisition news kept M&A in focus across the resource complex.
Biotech And Pharma Catalysts
Eli Lilly announced a gene therapy deal with Profluent worth up to $2.25 billion, adding a major partnership headline to the day. Bayer also drew attention after its Roundup litigation fight reached the U.S. Supreme Court, with shares sliding after a split ruling.
Capital Returns And Income
Dividend announcements were a recurring feature, including Energy Transfer’s quarterly payout of $0.3375 per share with a 7.09% forward yield, Triton’s four quarterly preferred dividends, and InsCorp’s $0.12 quarterly dividend. These headlines kept income-oriented names in view alongside the broader earnings and commodity moves.